Companies: 10,795·Total market cap: $144.5T
Microbix Biosystems Inc.

Microbix Biosystems Inc.

MBX.TOTSXHealthcare● Active
$0.27
+$0.00(+0.00%)
Market Cap$37409310
P/E Ratio
52W High$0.34
52W Low$0.21

Microbix Biosystems Inc.(MBX.TO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · MBX.TO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-092024-092023-092022-092021-09
Revenue
Revenue$18.59M$25.39M$16.51M$19.08M$18.59M
Cost of Revenue$8.73M$10.00M$9.03M$7.95M$7.55M
Gross Profit$9.85M$15.39M$7.48M$11.12M$11.04M
Gross Margin %(computed)53.02%60.61%45.30%58.32%59.40%
Operating Expenses
R&D Expenses$2.33M$2.13M$2.05M$1.80M$1.03M
G&A Expenses$0.00M$8.63M$6.53M$5.00M$4.22M
Total Operating Expenses$11.43M$11.49M$10.22M$8.51M$6.21M
Operating Income($1.58M)$3.91M($2.74M)$2.69M$4.84M
Operating Margin %(computed)-8.48%15.38%-16.57%14.11%26.01%
Interest Income$0.35M$0.69M$0.46M$0.08M$0.00M
Interest Expense$0.95M$0.92M$0.84M$0.83M$1.60M
Income Before Tax($2.30M)$3.67M($0.04M)$1.87M$3.23M
Income Tax Expense($0.06M)$0.15M$0.00M$0.08M$1.60M
Net Income($2.25M)$3.52M($0.04M)$1.79M$1.63M
Net Margin %(computed)-12.08%13.86%-0.24%9.38%8.77%
Per Share & EBITDA
EPS (Basic)$-0.02$0.03$-0.00$0.01$0.01
Wtd Avg Shares139.15M136.70M137.91M135.38M114.85M
EBITDA$0.43M$6.21M$1.96M$3.73M$5.66M
EBITDA Margin %(computed)2.30%24.44%11.85%19.55%30.43%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · CAD · M

深入了解Microbix Biosystems Inc.

关于Microbix Biosystems Inc.(MBX.TO)损益表

Microbix Biosystems Inc.(MBX.TO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,MBX.TO实现营收$0.02B,毛利润$0.01B(毛利率53.02%),净利润($0.00B)(净利率-12.08%)。

常见问题

MBX.TO · 4 问

Microbix Biosystems Inc.(MBX.TO)2025财年营收为$0.02B,同比down26.8%。

MBX.TO revenueMBX.TO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09